422 related articles for article (PubMed ID: 1320051)
1. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.
Oelkers W; Diederich S; Bähr V
J Clin Endocrinol Metab; 1992 Jul; 75(1):259-64. PubMed ID: 1320051
[TBL] [Abstract][Full Text] [Related]
2. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
Oelkers W; Bähr V
Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests.
Moreira AC; Martinez R; Castro M; Elias LL
Clin Endocrinol (Oxf); 1992 Jun; 36(6):545-51. PubMed ID: 1330381
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.
Quinkler M; Oelkers W; Remde H; Allolio B
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):17-24. PubMed ID: 25617169
[TBL] [Abstract][Full Text] [Related]
5. Addison's disease.
Nieman LK; Chanco Turner ML
Clin Dermatol; 2006; 24(4):276-80. PubMed ID: 16828409
[TBL] [Abstract][Full Text] [Related]
6. Primary vs secondary adrenal insufficiency: ACTH-stimulated aldosterone diagnostic cut-off values by tandem mass spectrometry.
Abraham SB; Abel BS; Sinaii N; Saverino E; Wade M; Nieman LK
Clin Endocrinol (Oxf); 2015 Sep; 83(3):308-14. PubMed ID: 25620457
[TBL] [Abstract][Full Text] [Related]
7. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
Cénac A; London A; Ménard J; Corvol P
Ann Endocrinol (Paris); 1975; 36(3):153-62. PubMed ID: 172005
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
[TBL] [Abstract][Full Text] [Related]
9. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
[TBL] [Abstract][Full Text] [Related]
10. The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man.
Weinberger MH; Kem DC; Gomez-Sanchez C; Kramer NJ; Martin BT; Nugent CA
J Lab Clin Med; 1975 Jun; 85(6):957-67. PubMed ID: 166119
[TBL] [Abstract][Full Text] [Related]
11. [Extended ACTH rapid test for differentiation of primary and secondary adrenal insufficiency].
Albert JP; Schirmer A; Hartmann F
Med Klin; 1980 Sep; 75(19):693-6. PubMed ID: 6253778
[TBL] [Abstract][Full Text] [Related]
12. Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.
Oelkers W; L'age M
Klin Wochenschr; 1976 Jul; 54(13):607-12. PubMed ID: 940296
[TBL] [Abstract][Full Text] [Related]
13. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
[TBL] [Abstract][Full Text] [Related]
14. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
15. Tuberculous Addison's disease: lack of normalization of adrenocortical function after anti-tuberculous chemotherapy.
Bhatia E; Jain SK; Gupta RK; Pandey R
Clin Endocrinol (Oxf); 1998 Mar; 48(3):355-9. PubMed ID: 9578827
[TBL] [Abstract][Full Text] [Related]
16. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency.
Flad TM; Conway JD; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1996 Nov; 45(5):529-34. PubMed ID: 8977748
[TBL] [Abstract][Full Text] [Related]
17. Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.
Brown JJ; Fraser R; Lever AF; Robertson JI; James VH; McCusker J; Wynn V
Q J Med; 1968 Jan; 37(145):97-118. PubMed ID: 4297956
[No Abstract] [Full Text] [Related]
18. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
19. Assessment of adrenal function in women heterozygous for adrenoleukodystrophy.
el-Deiry SS; Naidu S; Blevins LS; Ladenson PW
J Clin Endocrinol Metab; 1997 Mar; 82(3):856-60. PubMed ID: 9062496
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid replacement in Addison's disease.
Thompson DG; Mason AS; Goodwin FJ
Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
